-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical Network News, May 25th.
Recently, the NMPA official website released the latest batch of drug approval information.
Another enterprise of omeprazole sodium for injection passed the consistency evaluation.
Hainan Beite, Poinsettia, Kelun, and Sialon Pharmaceutical Co.
, Ltd.
received the approval on the same day.
Approved, the product has been evaluated by 7 companies so far.
The fourth batch of countries adopted pantoprazole sodium for injection, and the forthcoming fifth batch will have two more PPI injections.
Recently, the NMPA official website released the latest batch of drug approval information.
Another enterprise of omeprazole sodium for injection passed the consistency evaluation.
Hainan Beite, Poinsettia, Kelun, and Sialon Pharmaceutical Co.
, Ltd.
received the approval on the same day.
Approved, the product has been evaluated by 7 companies so far.
The fourth batch of countries adopted pantoprazole sodium for injection, and the forthcoming fifth batch will have two more PPI injections.
Figure 1: The latest review of enterprises with Omeprazole Sodium for Injection
Source: NMPA official website
Omeprazole is the world's first approved proton pump inhibitor.
Compared with other similar drugs, it has the advantages of wide indications, high safety, and obvious pharmacoeconomic advantages.
Omeprazole sodium for injection is mainly used for ulcers.
Bleeding, acute gastric mucosal injury, prevention of severe diseases (such as cerebral hemorrhage, severe trauma, etc.
) stress state and upper gastrointestinal bleeding caused by gastric surgery.
According to data from Menet.
com, the sales of omeprazole sodium for injection in China's urban public hospitals , county-level public hospitals, urban community centers, and township health centers (Chinese public medical institutions) will drop to 5 billion in 2020 due to the epidemic.
Yuan level, but still occupy the TOP1 throne of injection products for peptic ulcer treatment.
Compared with other similar drugs, it has the advantages of wide indications, high safety, and obvious pharmacoeconomic advantages.
Omeprazole sodium for injection is mainly used for ulcers.
Bleeding, acute gastric mucosal injury, prevention of severe diseases (such as cerebral hemorrhage, severe trauma, etc.
) stress state and upper gastrointestinal bleeding caused by gastric surgery.
According to data from Menet.
com, the sales of omeprazole sodium for injection in China's urban public hospitals , county-level public hospitals, urban community centers, and township health centers (Chinese public medical institutions) will drop to 5 billion in 2020 due to the epidemic.
Yuan level, but still occupy the TOP1 throne of injection products for peptic ulcer treatment.
Figure 2: The share of TOP5 companies in Omeprazole Sodium for Injection in 2020
Source: Mi Nei.
com, China's public medical institutions terminal competition pattern
com, China's public medical institutions terminal competition pattern
In 2020, in China's public medical institutions, Osaikon will occupy more than 40% of the market share of Omeprazole Sodium for injection.
At present, the company's two specifications have been reviewed; TOP2 is occupied by the original research pharmaceutical company AstraZeneca, TOP3, TO4 , Supplementary applications for consistency evaluation of TOP5 pharmaceutical companies are under review and approval.
At present, the company's two specifications have been reviewed; TOP2 is occupied by the original research pharmaceutical company AstraZeneca, TOP3, TO4 , Supplementary applications for consistency evaluation of TOP5 pharmaceutical companies are under review and approval.
As of now, in addition to Omeprazole Sodium for injection, the companies that have reviewed omeprazole sodium include Shandong Luoxin Pharmaceutical, Shandong New Times Pharmaceutical, Guangzhou Poinsettia Pharmaceutical, Hainan Beite Pharmaceutical, Hunan Kelun Pharmaceutical, and Hunan Saican.
Long Pharmaceutical has a total of 7 companies.
Long Pharmaceutical has a total of 7 companies.
Table 1: Sales and national procurement of PPI injections
Source: Mi Nei.
com, China's public medical institutions terminal competition pattern
com, China's public medical institutions terminal competition pattern
At present, among the best-selling PPI injections in public medical institutions in China, pantoprazole, esomeprazole (esomeprazole) and lansoprazole have been included in the national procurement, and there are no companies for rabeprazole injections.
According to reviews, ilaprazole is Livzon’s exclusive new drug.
According to reviews, ilaprazole is Livzon’s exclusive new drug.
Source: NMPA official website, Mi Nei.
com database
com database
Medical Network News, May 25th.
Recently, the NMPA official website released the latest batch of drug approval information.
Another enterprise of omeprazole sodium for injection passed the consistency evaluation.
Hainan Beite, Poinsettia, Kelun, and Sialon Pharmaceutical Co.
, Ltd.
received the approval on the same day.
Approved, the product has been evaluated by 7 companies so far.
The fourth batch of countries adopted pantoprazole sodium for injection, and the forthcoming fifth batch will have two more PPI injections.
Recently, the NMPA official website released the latest batch of drug approval information.
Another enterprise of omeprazole sodium for injection passed the consistency evaluation.
Hainan Beite, Poinsettia, Kelun, and Sialon Pharmaceutical Co.
, Ltd.
received the approval on the same day.
Approved, the product has been evaluated by 7 companies so far.
The fourth batch of countries adopted pantoprazole sodium for injection, and the forthcoming fifth batch will have two more PPI injections.
Figure 1: The latest review of enterprises with Omeprazole Sodium for Injection
Source: NMPA official website
Omeprazole is the world's first approved proton pump inhibitor.
Compared with other similar drugs, it has the advantages of wide indications, high safety, and obvious pharmacoeconomic advantages.
Omeprazole sodium for injection is mainly used for ulcers.
Bleeding, acute gastric mucosal injury, prevention of severe diseases (such as cerebral hemorrhage, severe trauma, etc.
) stress state and upper gastrointestinal bleeding caused by gastric surgery.
According to data from Menet.
com, the sales of omeprazole sodium for injection in China's urban public hospitals , county-level public hospitals, urban community centers, and township health centers (Chinese public medical institutions) will drop to 5 billion in 2020 due to the epidemic.
Yuan level, but still occupy the TOP1 throne of injection products for peptic ulcer treatment.
Compared with other similar drugs, it has the advantages of wide indications, high safety, and obvious pharmacoeconomic advantages.
Omeprazole sodium for injection is mainly used for ulcers.
Bleeding, acute gastric mucosal injury, prevention of severe diseases (such as cerebral hemorrhage, severe trauma, etc.
) stress state and upper gastrointestinal bleeding caused by gastric surgery.
According to data from Menet.
com, the sales of omeprazole sodium for injection in China's urban public hospitals , county-level public hospitals, urban community centers, and township health centers (Chinese public medical institutions) will drop to 5 billion in 2020 due to the epidemic.
Yuan level, but still occupy the TOP1 throne of injection products for peptic ulcer treatment.
Figure 2: The share of TOP5 companies in Omeprazole Sodium for Injection in 2020
Source: Mi Nei.
com, China's public medical institutions terminal competition pattern
com, China's public medical institutions terminal competition pattern
In 2020, in China's public medical institutions, Osaikon will occupy more than 40% of the market share of Omeprazole Sodium for injection.
At present, the company's two specifications have been reviewed; TOP2 is occupied by the original research pharmaceutical company AstraZeneca, TOP3, TO4 , Supplementary applications for consistency evaluation of TOP5 pharmaceutical companies are under review and approval.
At present, the company's two specifications have been reviewed; TOP2 is occupied by the original research pharmaceutical company AstraZeneca, TOP3, TO4 , Supplementary applications for consistency evaluation of TOP5 pharmaceutical companies are under review and approval.
As of now, in addition to Omeprazole Sodium for injection, the companies that have reviewed omeprazole sodium include Shandong Luoxin Pharmaceutical, Shandong New Times Pharmaceutical, Guangzhou Poinsettia Pharmaceutical, Hainan Beite Pharmaceutical, Hunan Kelun Pharmaceutical, and Hunan Saican.
Long Pharmaceutical has a total of 7 companies.
Long Pharmaceutical has a total of 7 companies.
Table 1: Sales and national procurement of PPI injections
Source: Mi Nei.
com, China's public medical institutions terminal competition pattern
com, China's public medical institutions terminal competition pattern
At present, among the best-selling PPI injections in public medical institutions in China, pantoprazole, esomeprazole (esomeprazole) and lansoprazole have been included in the national procurement, and there are no companies for rabeprazole injections.
According to reviews, ilaprazole is Livzon’s exclusive new drug.
According to reviews, ilaprazole is Livzon’s exclusive new drug.
Source: NMPA official website, Mi Nei.
com database
com database
Medical Network News, May 25th.
Recently, the NMPA official website released the latest batch of drug approval information.
Another enterprise of omeprazole sodium for injection passed the consistency evaluation.
Hainan Beite, Poinsettia, Kelun, and Sialon Pharmaceutical Co.
, Ltd.
received the approval on the same day.
Approved, the product has been evaluated by 7 companies so far.
The fourth batch of countries adopted pantoprazole sodium for injection, and the forthcoming fifth batch will have two more PPI injections.
Recently, the NMPA official website released the latest batch of drug approval information.
Another enterprise of omeprazole sodium for injection passed the consistency evaluation.
Hainan Beite, Poinsettia, Kelun, and Sialon Pharmaceutical Co.
, Ltd.
received the approval on the same day.
Approved, the product has been evaluated by 7 companies so far.
The fourth batch of countries adopted pantoprazole sodium for injection, and the forthcoming fifth batch will have two more PPI injections.
Figure 1: The latest review of enterprises with Omeprazole Sodium for Injection
Source: NMPA official website
Omeprazole is the world's first approved proton pump inhibitor.
Compared with other similar drugs, it has the advantages of wide indications, high safety, and obvious pharmacoeconomic advantages.
Omeprazole sodium for injection is mainly used for ulcers.
Bleeding, acute gastric mucosal injury, prevention of severe diseases (such as cerebral hemorrhage, severe trauma, etc.
) stress state and upper gastrointestinal bleeding caused by gastric surgery.
According to data from Menet.
com, the sales of omeprazole sodium for injection in China's urban public hospitals , county-level public hospitals, urban community centers, and township health centers (Chinese public medical institutions) will drop to 5 billion in 2020 due to the epidemic.
Yuan level, but still occupy the TOP1 throne of injection products for peptic ulcer treatment.
Disease disease disease hospital hospital hospitalCompared with other similar drugs, it has the advantages of wide indications, high safety, and obvious pharmacoeconomic advantages.
Omeprazole sodium for injection is mainly used for ulcers.
Bleeding, acute gastric mucosal injury, prevention of severe diseases (such as cerebral hemorrhage, severe trauma, etc.
) stress state and upper gastrointestinal bleeding caused by gastric surgery.
According to data from Menet.
com, the sales of omeprazole sodium for injection in China's urban public hospitals , county-level public hospitals, urban community centers, and township health centers (Chinese public medical institutions) will drop to 5 billion in 2020 due to the epidemic.
Yuan level, but still occupy the TOP1 throne of injection products for peptic ulcer treatment.
Figure 2: The share of TOP5 companies in Omeprazole Sodium for Injection in 2020
Source: Mi Nei.
com, China's public medical institutions terminal competition pattern
com, China's public medical institutions terminal competition pattern
In 2020, in China's public medical institutions, Osaikon will occupy more than 40% of the market share of Omeprazole Sodium for injection.
At present, the company's two specifications have been reviewed; TOP2 is occupied by the original research pharmaceutical company AstraZeneca, TOP3, TO4 , Supplementary applications for consistency evaluation of TOP5 pharmaceutical companies are under review and approval.
At present, the company's two specifications have been reviewed; TOP2 is occupied by the original research pharmaceutical company AstraZeneca, TOP3, TO4 , Supplementary applications for consistency evaluation of TOP5 pharmaceutical companies are under review and approval.
As of now, in addition to Omeprazole Sodium for injection, the companies that have reviewed omeprazole sodium include Shandong Luoxin Pharmaceutical, Shandong New Times Pharmaceutical, Guangzhou Poinsettia Pharmaceutical, Hainan Beite Pharmaceutical, Hunan Kelun Pharmaceutical, and Hunan Saican.
Long Pharmaceutical has a total of 7 companies.
Enterprise business enterpriseLong Pharmaceutical has a total of 7 companies.
Table 1: Sales and national procurement of PPI injections
Source: Mi Nei.
com, China's public medical institutions terminal competition pattern
com, China's public medical institutions terminal competition pattern
At present, among the best-selling PPI injections in public medical institutions in China, pantoprazole, esomeprazole (esomeprazole) and lansoprazole have been included in the national procurement, and there are no companies for rabeprazole injections.
According to reviews, ilaprazole is Livzon’s exclusive new drug.
According to reviews, ilaprazole is Livzon’s exclusive new drug.
Source: NMPA official website, Mi Nei.
com database
com database
